JNJ JOHNSON & JOHNSON IPO Launches 8-K Filing 2023 - IPO of Subsidiary Johnson & Johnson's subsidiary, Kenvue Inc., completed its initial public offering (IPO) and Johnson & Johnson will receive net proceeds of $4,241 million as partial consideration for the consumer health business transferred to Kenvue.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON